(Q31155701)

29 June 2017

title

Self-reported confusion is related to global and regional β-amyloid: data from the Women's healthy ageing project (English)

1 reference

29 June 2017

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108945%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Georgia E McCluskey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108945%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Victor L Villemagne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108945%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Christopher Rowe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108945%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Cassandra E I Szoeke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108945%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

1 reference

20 January 2017

1 reference

Brain Imaging and Behavior

29 June 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108945%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108945%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108945%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

78-86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108945%20AND%20SRC:MED&resulttype=core&format=json

Subjective Memory Impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Subjective cognitive complaints and amyloid burden in cognitively normal older individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Sex differences in the clinical manifestations of Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Minimizing confusion and disorientation: cognitive support work in informal dementia caregiving

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

The prognostic significance of subsyndromal delirium in elderly medical inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Memory complaints; the association with psycho-affective and health problems and the role of personality characteristics. A 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Prognosis of delirium in hospitalized elderly: worse than we thought

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Prevalence, presentation and prognosis of delirium in older people in the population, at home and in long term care: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Geriatric psychiatry review: differential diagnosis and treatment of the 3 D's - delirium, dementia, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Delirium accelerates cognitive decline in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Prognosis after hospital discharge of older medical patients with delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Diagnosing delirium in older emergency department patients: validity and reliability of the delirium triage screen and the brief confusion assessment method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Are memory complaints predictive for dementia? A review of clinical and population-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Pharmacological treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Molecular imaging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Brain dysfunction: another burden for the chronically critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

[Subjective memory loss--a sign of cognitive impairment in the elderly? An overview of the status of research].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Acute confusion in elderly medical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11682-016-9668-5